The induction of chromosomal aberrations (CAs) and sister-chromatid exchanges (SCEs) by the methylating agent streptozotocin (STZ) and the effect of this compound on mitotic index (MI) and cell cycle progression in human lymphocytes were investigated. Unstimulated (G 0) or cycling lymphocytes derived from whole blood or purified lymphocyte cultures were pulse-treated with increasing doses of STZ for 0.5–24 h. Induction of CAs by STZ was only observed in cycling lymphocytes derived from whole blood cultures (WBC) ( P<0.05). On the contrary, STZ produced a significant and dose–response increase in the yield of SCEs in unstimulated as well as cycling lymphocytes ( P<0.05). In addition, STZ induced a dose-dependent decrease in the MI but had a slight effect on cell cycle progression. These results suggest that SCEs are the most sensitive endpoint for evaluating the chromosomal effects of STZ on these cells.
Read full abstract